Goddard Glenn

Track

Insider profile

Performance

Overall performance
3.6
Performance over holding periods
3.6
30 days 90 days 120 days
Average return 7% 8.2% 15.1%
Success rate 75% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Goddard Glenn's trades of Intellia Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-01-05 2024-01-03
S Sale
50,531 -9.1%
146.48
US$570,207 		50,531 -9.1% 146.48 US$570,207
2023-01-06 2023-01-04
S Sale
43,541 -12.5%
157.28
US$1,319,784 		43,541 -12.5% 157.28 US$1,319,784
2022-03-03 2022-01-01
S Sale
29,175 -15.2%
159.02
US$2,288,421 		29,175 -15.2% 159.02 US$2,288,421
2021-09-01 2021-08-31
PlS Planned sale
24,800 -100.0%
160.22
US$3,973,456 		24,800 -100.0% 160.22 US$3,973,456
2021-09-01 2021-08-30
PlS Planned sale
300 -100.0%
160.84
US$48,252 		300 -100.0% 160.84 US$48,252
2021-09-01 2021-08-30
PlS Planned sale
300 -50.0%
159.53
US$47,859 		300 -50.0% 159.53 US$47,859
2021-09-01 2021-08-30
PlS Planned sale
300 -33.3%
158.42
US$47,526 		300 -33.3% 158.42 US$47,526
2021-09-01 2021-08-30
PlS Planned sale
496 -35.5%
157.33
US$78,036 		496 -35.5% 157.33 US$78,036
2021-09-01 2021-08-30
PlS Planned sale
300 -17.7%
156.10
US$46,830 		300 -17.7% 156.10 US$46,830
2021-09-01 2021-08-30
PlS Planned sale
1,700 -50.1%
155.29
US$263,993 		1,700 -50.1% 155.29 US$263,993
2021-09-01 2021-08-30
PlS Planned sale
1,100 -24.5%
154.29
US$169,719 		1,100 -24.5% 154.29 US$169,719
2021-09-01 2021-08-30
PlS Planned sale
704 -13.5%
153.22
US$107,867 		704 -13.5% 153.22 US$107,867